I was trying to post the picture of the Clinical Pipeline for CTIX. It has Kevetrin entering Phase two trial for AML and a Phase 2/3 trial for Advanced Solid Tumors. Is it to simplistic to say if they weren't already seeing efficacy the advanced solid tumors would also be a phase 2? Showing a phase 2/3 would imply efficacy? C'mon man, Granny needs a new pair of shoes.
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links